Mammographic features and clinical characteristics of different molecular subtypes of infiltrative ductal carcinoma

Chinese Journal of Medical Imaging Technology

Volumn 27, Issue 3, 2011, Pages 565-568

  Li, Rui ^a   Chen, Ying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Clinical characteristics; Molecular subtype; X rays

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CALCIFICATION; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CONTROLLED STUDY; DIGITAL MAMMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; ONSET AGE;

EID: 84860554300     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the Basal-like subtype of invasive breast cancer. Clin Cancer Res, 2004, 10(16): 5367-5374.
2. Yu K, Lee C H, Tan P H, et al. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res, 2004, 10(16): 5508-5517.
3. Van De Rijn M, Perou C M, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomaswith poor clinical outcome. Am J Pathol, 2002, 161(6): 1991-1996.
4. Obenauer S, Hermann K P, Grabbe E. Applications and literature review of the BI-RADS classification. Eur Radiol, 2005, 15(5): 1027-1036.
5. 2009, 25(1): 89-92.
6. 2001, 17(5): 431-433.
7. 2007, 28(6): 678-682.
8. Perou C M, Serlie T, Eisen M B, et al. Molecular portraits of human breast tumors. Nature, 2000, 406(17): 747-753.
9. Calza S, Hall P, Auer G, et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res, 2006, 8(4): R34.
10. Carey L A, Perou C M, Livasy C A, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295(21): 2492-2502.
11. Luck A A, Evans A J, James J J, et al. Breast carcinoma with basal phenotype: mammographic findings. AJR Am J Roentgenol, 2008, 191(2): 346-351.
12. Lamb P M, Perry N M, Vinnicombe S J, et al. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radio, 2000, 55(1): 40-44.
13. Paradiso A, Mangia A, Barlentta A, et al. Mammography and morphobiologic characteristics of human breast cancer. Tumori, 1993, 79(1): 422.
14. Kim M J, Ro J Y, Ahn S H, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol, 2006, 37(9): 1217-1226.
15. Fulford L G, Easton D F, Reis-Filho J S, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology, 2006, 49(1): 22-34.
16. Rakha E A, Putti T C, Abd El-Rehim D M, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol, 2006, 208(4): 495-506.